Plasma Protease C1-inhibitor Treatment Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Plasma Protease C1-inhibitor Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Plasma Protease C1-inhibitor Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Plasma Protease C1-inhibitor Treatment Overall Market Size
2.1 Global Plasma Protease C1-inhibitor Treatment Market Size: 2021 VS 2027
2.2 Global Plasma Protease C1-inhibitor Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Plasma Protease C1-inhibitor Treatment Players in Global Market
3.2 Top Global Plasma Protease C1-inhibitor Treatment Companies Ranked by Revenue
3.3 Global Plasma Protease C1-inhibitor Treatment Revenue by Companies
3.4 Top 3 and Top 5 Plasma Protease C1-inhibitor Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Plasma Protease C1-inhibitor Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasma Protease C1-inhibitor Treatment Players in Global Market
3.6.1 List of Global Tier 1 Plasma Protease C1-inhibitor Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Plasma Protease C1-inhibitor Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Plasma Protease C1-inhibitor Treatment Market Size Markets, 2021 & 2027
4.1.2 C1-inhibitors
4.1.3 Kallikrein Inhibitor (Kalbitor)
4.2 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue & Forecasts
4.2.1 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue, 2016-2021
4.2.2 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue, 2022-2027
4.2.3 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Plasma Protease C1-inhibitor Treatment Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Independent Pharmacies and Outlets
5.2 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue & Forecasts
5.2.1 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue, 2016-2021
5.2.2 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue, 2022-2027
5.2.3 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Plasma Protease C1-inhibitor Treatment Market Size, 2021 & 2027
6.2 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue & Forecasts
6.2.1 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue, 2016-2021
6.2.2 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue, 2022-2027
6.2.3 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Plasma Protease C1-inhibitor Treatment Revenue, 2016-2027
6.3.2 US Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.3.3 Canada Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.3.4 Mexico Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue, 2016-2027
6.4.2 Germany Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.4.3 France Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.4.4 U.K. Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.4.5 Italy Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.4.6 Russia Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.4.8 Benelux Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue, 2016-2027
6.5.2 China Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.5.3 Japan Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.5.4 South Korea Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.5.6 India Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Plasma Protease C1-inhibitor Treatment Revenue, 2016-2027
6.6.2 Brazil Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.6.3 Argentina Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue, 2016-2027
6.7.2 Turkey Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.7.3 Israel Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
6.7.5 UAE Plasma Protease C1-inhibitor Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Takeda
7.1.1 Takeda Corporate Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Plasma Protease C1-inhibitor Treatment Major Product Offerings
7.1.4 Takeda Plasma Protease C1-inhibitor Treatment Revenue in Global (2016-2021)
7.1.5 Takeda Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Plasma Protease C1-inhibitor Treatment Major Product Offerings
7.2.4 CSL Plasma Protease C1-inhibitor Treatment Revenue in Global (2016-2021)
7.2.5 CSL Key News
7.3 Sanquin
7.3.1 Sanquin Corporate Summary
7.3.2 Sanquin Business Overview
7.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Major Product Offerings
7.3.4 Sanquin Plasma Protease C1-inhibitor Treatment Revenue in Global (2016-2021)
7.3.5 Sanquin Key News
7.4 Pharming Group
7.4.1 Pharming Group Corporate Summary
7.4.2 Pharming Group Business Overview
7.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Major Product Offerings
7.4.4 Pharming Group Plasma Protease C1-inhibitor Treatment Revenue in Global (2016-2021)
7.4.5 Pharming Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Plasma Protease C1-inhibitor Treatment Market Opportunities & Trends in Global Market
Table 2. Plasma Protease C1-inhibitor Treatment Market Drivers in Global Market
Table 3. Plasma Protease C1-inhibitor Treatment Market Restraints in Global Market
Table 4. Key Players of Plasma Protease C1-inhibitor Treatment in Global Market
Table 5. Top Plasma Protease C1-inhibitor Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Plasma Protease C1-inhibitor Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Plasma Protease C1-inhibitor Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Plasma Protease C1-inhibitor Treatment Product Type
Table 9. List of Global Tier 1 Plasma Protease C1-inhibitor Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Plasma Protease C1-inhibitor Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Takeda Corporate Summary
Table 31. Takeda Plasma Protease C1-inhibitor Treatment Product Offerings
Table 32. Takeda Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2016-2021)
Table 33. CSL Corporate Summary
Table 34. CSL Plasma Protease C1-inhibitor Treatment Product Offerings
Table 35. CSL Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Sanquin Corporate Summary
Table 37. Sanquin Plasma Protease C1-inhibitor Treatment Product Offerings
Table 38. Sanquin Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Pharming Group Corporate Summary
Table 40. Pharming Group Plasma Protease C1-inhibitor Treatment Product Offerings
Table 41. Pharming Group Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Plasma Protease C1-inhibitor Treatment Segment by Type
Figure 2. Plasma Protease C1-inhibitor Treatment Segment by Application
Figure 3. Global Plasma Protease C1-inhibitor Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Plasma Protease C1-inhibitor Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Plasma Protease C1-inhibitor Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2020
Figure 8. By Type - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 12. US Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 24. China Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Takeda Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CSL Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sanquin Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Pharming Group Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)